| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Director | Stock Option (right to buy) | 8.64K | $51.4K | $3.35 | Jun 11, 2025 | Direct |
| Sage Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $7.79 | Jul 31, 2025 | Direct |
| Acumen Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 50K | Nov 6, 2025 | Direct | ||
| Shattuck Labs, Inc. | Director | Stock Option (Right to Buy) | 33.2K | Jul 14, 2025 | Direct | ||
| Sage Therapeutics, Inc. | Director | Stock Options (Right to buy) | 13.6K | Jan 3, 2025 | Direct | ||
| Sage Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Jul 31, 2025 | Direct |